| PUBCHEM ID |
23665631
|
| UNII |
2ZYM2BH34M
|
| Preferred Term |
PIRIPROST POTASSIUM
|
| CAS |
88851-62-1
|
| INCHIKEY |
UFJDMFZMRXDIKI-FFGYHVHASA-M
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCC[C@H](/C=C/[C@H]([C@H](C1)O)c(cc2CCCCC(O)=O)c1n2-c1ccccc1)O
|
| Total Surface Area |
345,62
|
| Relative PSA |
0,17132
|
| TPSA |
82,69
|
| cLogS |
-6,819
|
| MW |
425,567
|
| cLogP |
5,3474
|
| H-Acceptors |
5
|
| H-Donors |
3
|
| Ro5 violations |
1
|
| Druglikeness |
-14,309
|
| DrugScore |
0,172167116228577
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
0,6051
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,7615
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,7755
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,4739
|
| Carcinogenicity (Three-class) |
Non-required
|